JAMES BARKER: Open Payments
NPI 1922189927 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508,883 in 641 payments from 20 companies in 2025. Trend: 2023 $372,558 · 2024 $428,197 · 2025 $508,883
Speaker / faculty: $341,930Honoraria: $79,315Consulting: $40,690Travel & lodging: $34,397Food & beverage: $12,550
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 113 | $115,219 |
| Neurocrine BioSciences, Inc. | 93 | $92,183 |
| Alkermes, Inc. | 111 | $89,668 |
| Axsome Therapeutics, Inc. | 119 | $88,770 |
| Janssen Pharmaceuticals, Inc | 73 | $58,737 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 57 | $41,154 |
| Otsuka America Pharmaceutical, Inc. | 25 | $14,790 |
| Eli Lilly and Company | 4 | $7,393 |
| Vanda Pharmaceuticals Inc. | 8 | $211 |
| Teva Pharmaceuticals USA, Inc. | 8 | $196 |
Products named: COBENFY, INGREZZA, Auvelity, LYBALVI, CAPLYTA, SPRAVATO, ARISTADA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
